drugset / Trial / NCT03645668

Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients

NCT03645668

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The experimental and control group were used different administration of Meropenem through monitoring the Meropenem plasma concentration and clinical data

Timeline

Start
2018-01-30
Primary completion
2019-11-14
Completion
2019-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Meropenem Small molecule 1 g Intravenous